The latest and greatest new biomarkers - Which ones should we measure for risk prediction in our practice?

被引：9

作者：

de Lemos, James A. ^{[1
]}

机构：

[1] Univ Texas SW Med Ctr, Dallas, TX 75390 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2006年 / 166卷 / 22期

关键词：

D O I：

10.1001/archinte.166.22.2428

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2428 / 2430

页数：3

共 17 条

[1] Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old
Adams, Kenneth F.
Schatzkin, Arthur
Harris, Tamara B.
Kipnis, Victor
Mouw, Traci
Ballard-Barbash, Rachel
Hollenbeck, Albert
Leitzmann, Michael F.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (08) : 763 - 778
[2] Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study
Blankenberg, Stefan
McQueen, Matthew J.
Smieja, Marek
Pogue, Janice
Balion, Cynthia
Lonn, Eva
Rupprecht, Hans J.
Bickel, Christoph
Tiret, Laurence
Cambien, Francois
Gerstein, Hertzel
Muenzel, Thomas
Yusuf, Salim
[J]. CIRCULATION, 2006, 114 (03) : 201 - 208
[3] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Cleeman, JI
Grundy, SM
Becker, D
Clark, LT
Cooper, RS
Denke, MA
Howard, WJ
Hunninghake, DB
Illingworth, DR
Luepker, RV
McBride, P
McKenney, JM
Pasternak, RC
Stone, NJ
Van Horn, L
Brewer, HB
Ernst, ND
Gordon, D
Levy, D
Rifkind, B
Rossouw, JE
Savage, P
Haffner, SM
Orloff, DG
Proschan, MA
Schwartz, JS
Sempos, CT
Shero, ST
Murray, EZ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
[4] The effect of including C-reactive protein in cardiovascular risk prediction models for women
Cook, Nancy R.
Buring, Julie E.
Ridker, Paul M.
[J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (01) : 21 - 29
[5] B-type natriuretic peptide in cardiovascular disease
de Lemos, JA
McGuire, DK
Drazner, MH
[J]. LANCET, 2003, 362 (9380) : 316 - 322
[6] The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
de Lemos, JA
Morrow, DA
Bentley, JH
Omland, T
Sabatine, MS
McCabe, CH
Hall, C
Cannon, CP
Braunwald, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) : 1014 - 1021
[7] N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease -: A Global Utilization of Strategies to Open occluded arteries (GUSTO)-IV substudy
James, SK
Lindahl, B
Siegbahn, A
Stridsberg, M
Venge, P
Armstrong, P
Barnathan, ES
Califf, R
Topol, EJ
Simoons, ML
Wallentin, L
[J]. CIRCULATION, 2003, 108 (03) : 275 - 281
[8] N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
Kistorp, C
Raymond, I
Pedersen, F
Gustafsson, F
Faber, J
Hildebrandt, P
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (13): : 1609 - 1616
[9] N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
Kragelund, C
Gronning, B
Kober, L
Hildebrandt, P
Steffensen, R
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (07) : 666 - 675
[10] Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease
Lloyd-Jones, Donald M.
Liu, Kiang
Tian, Lu
Greenland, Philip
[J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (01) : 35 - 42

← 1 2 →